Bicalutamide: A Potential New Oral Anti-Androgenic Drug for Female Pattern Hair Loss - A Case Series
August 2026
in “
Cosmoderma
”
Studysummary This case series evaluated the use of oral bicalutamide with low-dose oral minoxidil in women with female pattern hair loss who didn't respond to minoxidil alone, finding that 96.6% showed improvement after six months without adverse effects.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on cosmoderma.org →